Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Lowered to “Buy” at StockNews.com
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Monday. Aurinia Pharmaceuticals Stock Performance Shares of AUPH opened at $7.61 on Monday. The company has a quick ratio of 5.11, a current ratio of 5.60 […]
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Monday. Aurinia Pharmaceuticals Stock Performance Shares of AUPH opened at $7.61 on Monday. The company has a quick ratio of 5.11, a current ratio of 5.60 […]
